Abuse of Proprietary (Over-the-Counter) Drugs

Adolescent Medicine Clinics

Volumn 17, Issue 3, 2006, Pages 733-750

  Williams, Janet F ^a   Kokotailo, Patricia K ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NON PRESCRIPTION DRUG;

ADDICTION; HUMAN; REVIEW; SUBSTANCE ABUSE; UNITED STATES;

DRUGS, NON-PRESCRIPTION; HUMANS; NONPRESCRIPTION DRUGS; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 33749340647     PISSN: 15473368     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.admecli.2006.06.006     Document Type: Review

References (45)

1. Wax P.M. Just a click away: recreational drug Web sites on the Internet. Pediatrics 109 (2002) e96
2. Boyer E.W., Shannon M., and Hibberd P.L. The Internet and psychoactive substance use among innovative drug users. Pediatrics 115 (2005) 302-305
3. Boyer E.W. Dextromethorphan abuse. Pediatr Emerg Care 20 (2004) 858-863
4. Crouch B.I., Caravati E.M., and Booth J. Trends in child and teen nonprescription drug abuse reported to a regional poison control center. Am J Health Syst Pharm 61 (2004) 1252-1257
5. Williams JF, Storck M, Committee on Substance Abuse, Committee on Native American Child Health. American Academy of Pediatrics. Clinical report: inhalant abuse. Pediatrics 2006, in press.
6. Balster R.L. Neural basis of inhalant abuse. Drug Alcohol Depend 51 (1998) 207-214
7. Romanelli F., Smith K.M., Thornton A.C., et al. Poppers: epidemiology and clinical management of inhaled nitrite abuse. Pharmacotherapy 24 (2004) 69-78
8. Wu L.T., Pilowsky D.J., and Schlenger W.E. Inhalant abuse and dependence among adolescents in the united states. J Am Acad Child Adolesc Psychiatry 43 (2004) 1206-1214
9. Neumark Y.D., Delva J., and Anthony J.C. The epidemiology of adolescent inhalant drug involvement. Arch Pediatr Adolesc Med 152 (1998) 781-786
10. Edwards R.W., and Oetting E.R. Inhalant use in the United States. NIDA Res Monogr 148 (1995) 8-28
11. Beauvais F., Wayman J.C.F., Jumper-Thurman P.F., et al. Inhalant abuse among American Indian, Mexican American, and non-Latino white adolescents. Am J Drug Alcohol Abuse 28 (2002) 171-187
12. Spiller H.A. Epidemiology of volatile substance abuse (VSA) cases reported to US poison centers. Am J Drug Alcohol Abuse 30 (2004) 155-165
13. Substance Abuse and Mental Health Services Association. Overview of findings from the 2004 national survey on drug use and health. Available at: http://www.drugabusestatistics.samhsa.gov/nsduh.htm#NSDUHinfo. Accessed December 2005.
14. Johnston LD, O'Malley PM, Bachman JG, et al. Monitoring the future national results on adolescent drug use: overview on key findings, 2005. Available at: http://www.monitoringthefuture.org/data/05data.html#2005data-drugs. Accessed December 2005.
15. Beauvais F., Chavez E.L., Oetting E.R., et al. Drug use, violence and victimization among white American, Mexican American, and American Indian dropouts, students with academic problems, and students in good academic standing. J Counsel Psychol 43 (1996) 292-299
16. Howard M.O., and Jenson J.M. Inhalant use among antisocial youth: prevalence and correlates. Addict Behav 24 (1999) 59-74
17. Sakai J.T., Hall S.K., Mikulich-Gilbertson S.K., et al. Inhalant use, abuse, and dependence among adolescent patients: commonly comorbid problems. J Am Acad Child Adolesc Psychiatry 43 (2004) 1080-1088
18. Beauvais F. Comparison of drug use rates for reservation Indian, non-reservation Indian and Anglo youth. Am Indian Alsk Native Ment Health Res 5 (1992) 13-31
19. Lorenc J.D. Inhalant abuse in the pediatric population: a persistent challenge. Curr Opin Pediatr 15 (2003) 204-209
20. Brouette T., and Anton R. Clinical review of inhalants. Am J Addict 10 (2001) 79-94
21. Ramsey J., Anderson H.R., Bloor K., et al. An introduction to the practice prevalence and chemical toxicology of volatile substance abuse. Hum Toxicol 8 (1989) 261-269
22. Shepherd R.T. Mechanism of sudden death associated with volatile substance abuse. Hum Toxicol 8 (1989) 287-291
23. Meadows R., and Verghese A. Medical complications of glue sniffing. South Med J 89 (1996) 455-462
24. Rosenberg N.L., Grigsby J., Dreisbach J., et al. Neuropsychologic impairment and MRI abnormalities associated with chronic solvent abuse. J Toxicol Clin Toxicol 40 (2002) 21-34
25. Broussard L.A. The role of the laboratory in detecting inhalant abuse. Clin Lab Sci 13 (2000) 205-209
26. Jumper-Thurman P., Plested B., and Beauvais F. Treatment strategies for volatile solvent abusers in the United States. NIDA Res Monogr 148 (1995) 250-259
27. Bobo W.V., Miller S.C., and Martin B.D. The abuse liability of dextromethrophan among adolescents: a review. J Child Adolesc Subst Abuse 14 (2005) 55-75
28. Paul I.M., Yoder K.E., Crowell K.R., et al. Effect of dextromethorphan, diphenhydramine, and placebo on nocturnal cough and sleep quality for coughing children and their parents. Pediatrics 114 (2004) 85-90
29. Schwartz R.H. Adolescent abuse of dextromethorphan. Clin Pediatr 44 (2005) 565-568
30. Banerji S., and Anderson I.B. Abuse of Coricidin HBP Cough & Cold tablets: episodes recorded by a poison control center. Am J Health Syst Pharm 58 (2001) 1811-1814
31. Watson W. Toxic exposure surveillance system dextromethorphan data (2003), American Association of Poison Control Centers, Washington (DC)
32. Noonan W.C., Miller W.R., and Feeney D.M. Dextromethorphan abuse among youth. Arch Fam Med 9 (2000) 791-792
33. Darboe M.N., Keenan Jr. G.R., and Richards T.K. The abuse of dextromethorphan-based cough syrup; a pilot study of the community of Waynesboro, Pennsylvania. Adolescence 31 (1996) 633-644
34. Miller S.C. Treatment of dextromethorphan dependence with naltrexone. Addict Disord Their Treatment 4 (2005) 145-148
35. Rowe C., Verjee Z., and Koren G. Adolescent dimenhydrinate abuse: resurgence of an old problem. J Adolesc Health 21 (1997) 47-49
36. Nguyen L., Mallari J., and Goad J.A. Non-prescription household substances of abuse. California Pharmacist 5 (2005) 29-34
37. Griffiths R.R., Juliano L.M., and Chausmer A.L. Caffeine: pharmacology and clinical effects. In: Graham A.W., Schultz T.K., Mayo-Smith M.F., et al. (Eds). Principles of addiction medicine. 3rd edition (2003), American Society of Addiction Medicine, Chevy Chase (MD)
38. Griffiths R.R., and Chausmer A.L. Caffeine as a model drug of dependence: recent developments in understanding caffeine withdrawal, the caffeine dependence syndrome, and caffeine negative reinforcement. Jpn J Neuropsychopharmacol 20 (2000) 223-231
39. Goldstein A., and Wallace M.E. Caffeine dependence in schoolchildren?. Exp Clin Psychopharmacol 5 (1997) 388-392
40. Bernstein G.A., Carroll M.E., Dean N.W., et al. Caffeine withdrawal in normal school-age children. J Am Acad Child Adolesc Psychiatry 37 (1998) 858-865
41. Bernstein G.A., Carroll M.E., Thuras P.D., et al. Caffeine dependence in teenagers. Drug Alcohol Depend 66 (2002) 1-6
42. Fiore MC, Bailey WC, Cohen SJ, et al. Treating tobacco use and dependence. Clinical practice guideline. Rockville (MD): US Department of Health and Human Services. Public Health Service. June 2000.
43. Klesges L.M., Johnson K.C., Somes G., et al. Use of nicotine replacement therapy in adolescent smokers and nonsmokers. Arch Pediatr Adolesc Med 157 (2003) 517-522
44. Hughes J.R., Pillitteri J.L., Callas P.W., et al. Misuse of and dependence on over-the-counter nicotine gum in a volunteer sample. Nicotine Tob Res 6 (2004) 79-84
45. Hyland A., Bradford D., and Gitchell J. Drug counselor report of adolescents' abuse of nicotine replacement therapy. J Addict Dis 24 (2005) 105-113